[go: up one dir, main page]

NO994527D0 - 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi - Google Patents

2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi

Info

Publication number
NO994527D0
NO994527D0 NO994527A NO994527A NO994527D0 NO 994527 D0 NO994527 D0 NO 994527D0 NO 994527 A NO994527 A NO 994527A NO 994527 A NO994527 A NO 994527A NO 994527 D0 NO994527 D0 NO 994527D0
Authority
NO
Norway
Prior art keywords
dihydrofuro
pyridine
therapy
preparation
Prior art date
Application number
NO994527A
Other languages
English (en)
Other versions
NO994527L (no
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO994527D0 publication Critical patent/NO994527D0/no
Publication of NO994527L publication Critical patent/NO994527L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO994527A 1997-03-20 1999-09-17 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi NO994527L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
NO994527D0 true NO994527D0 (no) 1999-09-17
NO994527L NO994527L (no) 1999-11-18

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994527A NO994527L (no) 1997-03-20 1999-09-17 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi

Country Status (22)

Country Link
US (1) US6143761A (no)
EP (1) EP0971929A1 (no)
JP (1) JP2001518099A (no)
KR (1) KR20000076282A (no)
CN (1) CN1251105A (no)
AR (1) AR012097A1 (no)
AU (1) AU6924298A (no)
BG (1) BG103684A (no)
BR (1) BR9808346A (no)
CA (1) CA2282320A1 (no)
CO (1) CO4940417A1 (no)
EE (1) EE9900414A (no)
FR (1) FR2761072B1 (no)
HU (1) HUP0002335A3 (no)
IL (1) IL131254A0 (no)
NO (1) NO994527L (no)
NZ (1) NZ337566A (no)
PL (1) PL335759A1 (no)
SK (1) SK127699A3 (no)
TR (1) TR199902115T2 (no)
WO (1) WO1998042713A1 (no)
ZA (1) ZA982365B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005139A1 (en) * 1995-07-28 1997-02-13 Abbott Laboratories Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission

Also Published As

Publication number Publication date
NO994527L (no) 1999-11-18
CA2282320A1 (en) 1998-10-01
NZ337566A (en) 2000-09-29
CN1251105A (zh) 2000-04-19
US6143761A (en) 2000-11-07
SK127699A3 (en) 2000-05-16
CO4940417A1 (es) 2000-07-24
HUP0002335A3 (en) 2002-07-29
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
AU6924298A (en) 1998-10-20
FR2761072B1 (fr) 1999-04-23
BR9808346A (pt) 2000-05-23
IL131254A0 (en) 2001-01-28
WO1998042713A1 (fr) 1998-10-01
EE9900414A (et) 2000-04-17
ZA982365B (en) 1998-09-23
EP0971929A1 (fr) 2000-01-19
KR20000076282A (ko) 2000-12-26
JP2001518099A (ja) 2001-10-09
HUP0002335A2 (hu) 2001-05-28
AR012097A1 (es) 2000-09-27
FR2761072A1 (fr) 1998-09-25
BG103684A (en) 2000-06-30

Similar Documents

Publication Publication Date Title
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
IL126900A0 (en) Spiro-piperidine derivatives and their use as therapeutic agents
NO944187D0 (no) Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
FI944600L (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
HUP0102549A3 (en) Platinum complex, its preparation and therapeutic application
NO991624D0 (no) 1H-pyrido[3,4-b]indol-4-karboksamid-derivater, fremstilling og anvendelse derav i terapeutiske midler
AU1280100A (en) Novel 2-pyridone derivatives, preparation method and therapeutic use
PL327854A1 (en) Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents
IL87089A0 (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
NO994527D0 (no) 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi
NO20000462D0 (no) 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid derivater, deres fremstilling og deres anvendelse i terapi
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
ZA922952B (en) 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA892841B (en) Benzothiazepin-4-one derivative,their preparation and their application in therapy
HUP0102409A2 (hu) Pirimidin- (amino-metil) -pirimidin-származékok, előállításuk és felhasználásuk Helicobacter baktériumok ellen
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
IL96706A0 (en) 3-substituted pyridines,their manufacture and their use as fungicides
IE882403L (en) 2-£(4-PIPERIDYL)METHYL|BENZOFURO£2,3-c|PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
SI0991650T1 (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application